Starboard created us on strategy benefits to everyone. sheet range LP. we capital as have Thank Value inherent and balance from We we to morning, with potential ready-access This enabling our of remain good a adopted you, strategic leverages strategy of the strong transactions. executing alliance flexibility Rob, our the focused the foundation committed that pursue and also
within to the work continue acquisitions value evaluating cap potential small We sector. with Starboard Value
Our primary set equity public market. sub the billion remains opportunity $X
As as the of efficient primary permanent one capital we this and that the have we approach view research area our favors in structure. past, said segment and the least market
year last has idea with flow, of the the increasing. robust Over our concerns validity top performance the slowed interest market however rate funnel and --
to an of see We public in beginning number again. are market the increase opportunities,
assist have private We two to us private selected added our to public equity transactions. and executives team in
financial acquire companies mature segments. to is services and goal operating in certain Our healthcare, technology, industrial
continue Bioscience, of outcome existing public were Board immediate to in evaluate April of engagement review maximize we heavily are its review new shareholder On involved. of XX, in two in which implementation strategic on value a one we to number return the culminating our assets This was announced our developments opportunities, As holdings. part Arix changes. There highlight. recent the we
result is of this the and a Formerly General now of Chief a to was recruiting permanent Operating As Arix Interim Board. appointed Lyne, named Counsel CEO and Arix review CEO. Rob Officer
Kohlberg Isaac were to Arix Non-Executive to as appointed Directors. nominees, and Acacia Board addition O'Connell the In Maureen of
very joined Moncreiffe period, Peregrine Arix. distinguished Chairman. of another as company over investment of Chairman Board the Peregrine Finally, we as an record as has Chairman established and a listed are him to Non-Executive extended have fortunate
these million or And new changes raised company shareholders. its $XXX is by responsive is of GBPXXX ensure supportive our that that governance this month, the Board billion. served very improvements at are a in these of million investment We Oxford corporate valuation believe and $X.X earlier Nanopore to
the public as successful plans first Immunocore This well. complete follows to Oxford offering. initial As this quarter in transaction, part announced of by Nanopore IPO also an the
realization. can and All for enhanced value liquidity options help to the these transactions us for increased deliver of us
to working the can all continue be life exercise. of maximize portfolio. sciences a our value time-consuming This We
of for With including to realization year such, complete to continue business, resulted and the efficient balanced we properly evaluate shareholders. will soft the made sized well most litigation. in respect our the a both the licensing to portfolio, past investments options and value over As our IP
Our call team Rich? is to actively discuss to number opportunities. Rosenstein, Rich advancing With that, like our our I'd a results. turn and of the over CFO